ModelEdge

Five Prime Therapeutics, Inc.
0001175505
Filing Type8-K
Filing Date4/15/2021
Updated4/16/21, 2:38 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-10.1EX-10.1